These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. Chernesky M, Jang D, Luinstra K, Chong S, Smieja M, Cai W, Hayhoe B, Portillo E, Macritchie C, Main C, Ewert R. J Clin Microbiol; 2006 Feb; 44(2):400-5. PubMed ID: 16455891 [Abstract] [Full Text] [Related]
11. Comparison of APTIMA COMBO 2 assay with polymerase chain reaction Roche assay for detection of Chlamydia trachomatis in endocervical swabs. Khryanin AA, Reshetnikov OV, Vlaspolder F. Int J STD AIDS; 2007 Dec; 18(12):871-2. PubMed ID: 18073027 [No Abstract] [Full Text] [Related]
12. Clinical evaluation of a new Pap test-based method for screening of Chlamydia trachomatis and Neisseria gonorrhoeae using liquid-based cytology media. Martens MG, Fine P, Fuller D, Ginde SY, Hook EW, Lebed J, Mena L, Taylor SN, Van Der Pol B. South Med J; 2013 Sep; 106(9):506-12. PubMed ID: 24002555 [Abstract] [Full Text] [Related]
13. Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting. Ho MK, Lo JY, Lo AC, Cheng FK, Chan FK. Sex Transm Infect; 2009 Sep; 85(5):322-5. PubMed ID: 19406739 [Abstract] [Full Text] [Related]
14. Comparison of methods for detection of Chlamydia trachomatis and Neisseria gonorrhoeae using commercially available nucleic acid amplification tests and a liquid pap smear medium. Koumans EH, Black CM, Markowitz LE, Unger E, Pierce A, Sawyer MK, Papp JR. J Clin Microbiol; 2003 Apr; 41(4):1507-11. PubMed ID: 12682137 [Abstract] [Full Text] [Related]
15. Comparison of the BD Viper System with XTR Technology to the Gen-Probe APTIMA COMBO 2 Assay using the TIGRIS DTS system for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine specimens. Mushanski LM, Brandt K, Coffin N, Levett PN, Horsman GB, Rank EL. Sex Transm Dis; 2012 Jul; 39(7):514-7. PubMed ID: 22706212 [Abstract] [Full Text] [Related]
16. Comparison of three assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in SurePath Pap samples and the role of pre- and postcytology testing. Chernesky M, Jang D, Portillo E, Smieja M, Kapala J, Doucette C, Sumner J, Ewert R, MacRitchie C, Gilchrist J. J Clin Microbiol; 2012 Apr; 50(4):1281-4. PubMed ID: 22259215 [Abstract] [Full Text] [Related]
17. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse. Black CM, Driebe EM, Howard LA, Fajman NN, Sawyer MK, Girardet RG, Sautter RL, Greenwald E, Beck-Sague CM, Unger ER, Igietseme JU, Hammerschlag MR. Pediatr Infect Dis J; 2009 Jul; 28(7):608-13. PubMed ID: 19451856 [Abstract] [Full Text] [Related]